Stephen W. Kidder’s AbbVie ABBV Stock Holding History

Stephen W. Kidder’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.71M	Sell	12,481 -25	-0.2%	-$5.55K	0.8%	34
2025 Q4	$2.86M	Sell	12,506 -35	-0.3%	-$7.97K	0.81%	33
2025 Q3	$2.9M	Sell	12,541 -115	-0.9%	-$23.4K	0.83%	32
2025 Q2	$2.35M	Sell	12,656 -185	-1%	-$34.4K	0.71%	32
2025 Q1	$2.69M	Sell	12,841 -175	-1%	-$34K	0.84%	29
2024 Q4	$2.31M	Sell	13,016 -80	-0.6%	-$14.7K	0.7%	34
2024 Q3	$2.59M	Sell	13,096 -120	-0.9%	-$22.4K	0.76%	32
2024 Q2	$2.27M	Sell	13,216 -110	-0.8%	-$18.2K	0.71%	32
2024 Q1	$2.43M	Sell	13,326 -800	-6%	-$138K	0.77%	30
2023 Q4	$2.19M	Sell	14,126 -371	-3%	-$54.1K	0.71%	30
2023 Q3	$2.16M	Sell	14,497 -470	-3%	-$69K	0.75%	31
2023 Q2	$2.02M	Sell	14,967 -508	-3%	-$74.5K	0.66%	32
2023 Q1	$2.47M	Sell	15,475 -590	-4%	-$90.2K	0.86%	33
2022 Q4	$2.6M	Buy	16,065 +2,390	+17%	+$366K	0.95%	31
2022 Q3	$1.84M	Sell	13,675 -265	-2%	-$38K	0.75%	35
2022 Q2	$2.13M	Sell	13,940 -1,575	-10%	-$241K	0.83%	32
2022 Q1	$2.52M	Sell	15,515 -582	-4%	-$84.5K	0.81%	35
2021 Q4	$2.18M	Sell	16,097 -4,168	-21%	-$492K	0.66%	37
2021 Q3	$2.19M	Sell	20,265 -45	-0.2%	-$5.14K	0.69%	38
2021 Q2	$2.29M	Buy	20,310 +1,315	+7%	+$148K	0.71%	38
2021 Q1	$2.06M	Sell	18,995 -210	-1%	-$22.5K	0.66%	38
2020 Q4	$2.06M	Sell	19,205 -2,500	-12%	-$240K	0.68%	37
2020 Q3	$1.9M	Sell	21,705 -100	-0.5%	-$9.41K	0.67%	38
2020 Q2	$2.14M	Sell	21,805 -619	-3%	-$54.5K	0.82%	34
2020 Q1	$1.71M	Sell	22,424 -225	-1%	-$19.2K	0.78%	34
2019 Q4	$2M	Sell	22,649 -50	-0.2%	-$4.15K	0.74%	35
2019 Q3	$1.72M	Buy	22,699 +365	+2%	+$25K	0.68%	37
2019 Q2	$1.62M	Sell	22,334 -74	-0.3%	-$5.82K	0.65%	38
2019 Q1	$1.8M	Sell	22,408 -7,350	-25%	-$601K	0.73%	38
2018 Q4	$2.74M	Sell	29,758 -1,915	-6%	-$168K	1.21%	28
2018 Q3	$3M	Sell	31,673 -235	-0.7%	-$22.3K	1.09%	29
2018 Q2	$2.96M	Sell	31,908 -1,110	-3%	-$108K	1.13%	29
2018 Q1	$3.13M	Sell	33,018 -3,870	-10%	-$425K	1.19%	30
2017 Q4	$3.57M	Sell	36,888 -835	-2%	-$78.7K	1.28%	29
2017 Q3	$3.35M	Buy	37,723 +918	+2%	+$69.9K	1.24%	30
2017 Q2	$2.67M	Sell	36,805 -75	-0.2%	-$5.04K	1.01%	32
2017 Q1	$2.4M	Sell	36,880 -1,380	-4%	-$86.8K	0.92%	35
2016 Q4	$2.4M	Sell	38,260 -25	-0.1%	-$1.53K	0.97%	34
2016 Q3	$2.41M	Sell	38,285 -25	-0.1%	-$1.62K	0.96%	34
2016 Q2	$2.37M	Buy	38,310 +500	+1%	+$30.5K	0.94%	33
2016 Q1	$2.16M	Buy	37,810 +2,220	+6%	+$124K	0.88%	37
2015 Q4	$2.11M	Buy	35,590 +11,925	+50%	+$687K	0.9%	35
2015 Q3	$1.29M	Hold	23,665	–	–	0.65%	41
2015 Q2	$1.59M	Sell	23,665 -1,700	-7%	-$111K	0.72%	41
2015 Q1	$1.49M	Hold	25,365	–	–	0.64%	47
2014 Q4	$1.66M	Sell	25,365 -400	-2%	-$25.2K	0.72%	42
2014 Q3	$1.49M	Buy	25,765 +20,605	+399%	+$1.14M	0.68%	43
2014 Q2	$292K	Sell	5,160 -800	-13%	-$42K	0.19%	54
2014 Q1	$306K	Sell	5,960 -550	-8%	-$27.8K	0.21%	56
2013 Q4	$343K	Hold	6,510	–	–	0.24%	52
2013 Q3	$292K	Sell	6,510 -392	-6%	-$17.4K	0.23%	53
2013 Q2	$284K	Buy	+6,902	New	+$302K	0.23%	55

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stephen W. Kidder's ABBV Position: Q1 2026 in Review

Stephen W. Kidder reduced its AbbVie (ABBV) stake by 0.2% in Q1 2026, selling an estimated $5.55K and leaving 12,481 shares worth $2.71M. The position accounts for 0.8% of the portfolio, ranked #34.

Stephen W. Kidder first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.57M in Q4 2017. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Stephen W. Kidder held 12,481 shares of AbbVie worth $2.71M as of Q1 2026.
Stephen W. Kidder sold 25 AbbVie shares in Q1 2026, an estimated $5.55K.
AbbVie made up 0.8% of Stephen W. Kidder's portfolio in Q1 2026, its #34 holding.
Stephen W. Kidder first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
Stephen W. Kidder's AbbVie position peaked at $3.57M in Q4 2017.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Stephen W. Kidder's 13F filing for Q1 2026, filed 11 May 2026.